Summary statements

• The randomized controlled trials comparing combination LT3/LT4 therapy did not specifically recruit patients with attention to persistent hypothyroid symptoms or dissatisfaction.

• It is possible that those individuals most likely to benefit from combination therapy may not yet have been included in trials in sufficient numbers to provide adequate power for detecting a response.